| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |